株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

血液透析用人工血管市場規模、シェア、動向分析レポート:原材料別(ポリエステル、ポリテトラフルオロエチレン、ポリウレタン、生物学的材料)、セグメント予測

Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials), And Segment Forecasts, 2019 - 2025

発行 Grand View Research, Inc. 商品コード 785991
出版日 ページ情報 英文 77 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
血液透析用人工血管市場規模、シェア、動向分析レポート:原材料別(ポリエステル、ポリテトラフルオロエチレン、ポリウレタン、生物学的材料)、セグメント予測 Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials), And Segment Forecasts, 2019 - 2025
出版日: 2019年01月02日 ページ情報: 英文 77 Pages
概要

当レポートでは、世界の血液透析用人工血管市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 エグゼクティブサマリー

第2章 調査方法

第3章 市場変数、動向、範囲

  • 市場セグメンテーションと範囲
    • 市場促進因子
    • 市場阻害因子
  • PESTLE分析
  • 業界分析
  • 市場法規制シナリオ
  • 平均販売価格

第4章 原材料別予測と動向分析

  • 動向分析
  • ポリエステル
  • ポリテトラフルオロエチレン
  • ポリウレタン
  • 生物学的材料

第5章 地域別予測と動向分析

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合環境

  • 戦略枠組み
  • 企業プロファイル
    • W. L. Gore & Associates.
    • C. R. Bard, Inc.
    • Terumo Medical Corporation.
    • Lemaitre Vascular, Inc.
    • Getinge AB.
    • VASCULAR GENESIS.
    • InnAVasc Medical, Inc.
    • CryoLife, Inc.
    • MERIT MEDICAL SYSTEMS, INC
    • Proteon Therapeutics Inc.
図表

List of Tables

  • TABLE 1 Comparative analysis of country wise out of pocket healthcare expenditure (% of private expenditure on health) in 2012,2013, 2014 and 2015
  • TABLE 2 Comparative analysis of country wise HD/PD cost ratio
  • TABLE 3 U.S. Regulatory framework
  • TABLE 4 Canada Regulatory Framework
  • TABLE 5 Europe Regulatory Framework
  • TABLE 6 China Regulatory Framework
  • TABLE 7 Japan Regulatory framework
  • TABLE 8 Brazil Regulatory Framework
  • TABLE 9 Mexico Regulatory Framework
  • TABLE 10 South Africa Regulatory Framework
  • TABLE 11 North America hemodialysis vascular graft market estimates and forecasts, by raw material 2014 - 2025 (USD Millions)
  • TABLE 12 Europe hemodialysis vascular graft market estimates and forecasts, by raw material 2014 - 2025 (USD Millions)
  • TABLE 13 Asia Pacific hemodialysis vascular graft market estimates and forecasts, by raw material 2014 - 2025 (USD Millions)
  • TABLE 14 Latin America hemodialysis vascular graft market estimates and forecasts, by raw material 2014 - 2025 (USD Millions)
  • TABLE 15 MEA hemodialysis vascular graft market estimates and forecasts, by raw material 2014 - 2025 (USD Millions)

List of Figures

  • FIG. 1 Market summary, 2017 (USD Million)
  • FIG. 2 Market Research Process
  • FIG. 3 Information Procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market trends & outlook
  • FIG. 6 Market segmentation & scope
  • FIG. 7 Market driver relevance analysis (Current & future impact)
  • FIG. 8 Market restraint relevance analysis (Current & future impact)
  • FIG. 9 Global Hemodialysis Vascular Grafts Market - PESTEL analysis
  • FIG. 10 Porter's Five Forces Analysis
  • FIG. 11 Global hemodialysis vascular grafts market: Raw material outlook key takeaways, USD Million
  • FIG. 12 Global hemodialysis vascular grafts market: Raw material movement analysis, USD Million
  • FIG. 13 Polyester hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 14 Polytetrafluoroethylene hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 15 Polyurethane hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 16 Biological materials hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 17 Human saphenous and umbilical veins biological material hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 18 Tissue engineered biological material hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 19 Regional market place: Key takeaways
  • FIG. 20 Regional outlook, 2017 & 2025
  • FIG. 21 North America hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 22 U.S. hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 23 Canada hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 24 Europe hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 25 U.K. hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 26 Germany hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 27 Asia Pacific hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 28 Japan hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 29 China hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 30 Latin America hemodialysis vascular graft, market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 31 Brazil hemodialysis vascular graft, market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 32 Mexico hemodialysis vascular graft, market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 33 MEA hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 34 South Africa hemodialysis vascular graft market estimates and forecasts, 2014 - 2025 (USD Million)
目次
Product Code: GVR-2-68038-731-5

The global hemodialysis vascular grafts market size is expected to reach USD 276.5 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 4.1% during the forecast period. Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.

The global hemodialysis vascular grafts market, by raw material, was dominated by PTFE grafts with a revenue share of 45.0% in 2018. The segment is anticipated to maintain its position throughout the forecast period. High product penetration, wide availability, and comparatively cheaper products are supplementing the dominance of the segment. Moreover, recent development of biological grafts for hemodialysis is expected to increase its adoption, owing to lower possibility of rejection and infection of these products.

North America dominated the market in 2018 and accounted for approximately 32.0% of the overall revenue. The U.S. is a key revenue contributor not only in the region but at the global marketplace as well. The growth of the market in the country can be attributed to growing number of renal impaired patients undergoing hemodialysis and surging demand for AVGs required to create superficial access for blood transfusion.

Developing economies such as China and India have lower availability of kidney donors as compared to developed economies. Thus patients opt for alternatives such as hemodialysis. Increase in number of hemodialysis procedures is expected to drive the market between 2018 and 2025. Asia Pacific is poised to exhibit a CAGR of 6.6% between 2018 and 2025, owing to increasing number of patients with CKD, growing awareness regarding safety of AVG, and rising healthcare expenditure.

Further key findings from the study suggest:

North America dominated the market in 2017, owing to geightened awareness regarding treatment options available, increasing adoption of hemodialysis access grafts, and technological advancements in AVG

Asia Pacific is anticipated to be the fastest growing regional market with a CAGR of 6.6 % between 2018 and 2025

Some of the key market players in this market are W.L. Gore & Associates; C. R. Bard, Inc.; Terumo Medical Corporation; LeMaitre Vascular, Inc.; Getinge AB; Vascular Genesis; InnAVasc Medical, Inc.; CryoLife, Inc.; Merit Medical Systems, Inc.; and Proteon Therapeutics, Inc.

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Snapshot, 2017 (USD Million)

Chapter 2 Research Methodology

  • 2.1 Information procurement

Chapter 3 Market Variables, Trends& Scope

  • 3.1 Market Segmentation& Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Increase in prevalence of renal disorders
      • 3.1.1.2 Presence of well-defined regulatory guidelines in developed economies
      • 3.1.1.3 Increasing adoption of biological access grafts
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Low reimbursement rate and high out-of-pocket expenditure in emerging markets
      • 3.1.2.2 Economic pricing for peritoneal dialysis procedures
      • 3.1.2.3 Low diagnosis rate of patients with kidney diseases
      • 3.1.2.4 Increase in number of patients undergoing peritoneal dialysis in developed economies
  • 3.2 Global hemodialysis vascular grafts market - PESTEL Analysis
  • 3.3 Industry Analysis - Porter's
  • 3.4 Global Hemodialysis Vascular Grafts Market Regulatory Scenario
  • 3.5 Average Selling Price by Product, USD (2014 to 2025)

Chapter 4 Global Hemodialysis Vascular Grafts Market: Raw Material Estimates & Trend Analysis

  • 4.1 Global hemodialysis vascular grafts market: Raw material movement analysis
  • 4.2 Polyester
    • 4.2.1 Hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.3 Polytetrafluoroethylene
    • 4.3.1 Market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.4 Polyurethane
    • 4.4.1 Hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.5 Biological materials
    • 4.5.1 Market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.5.2 Human Saphenous and Umbilical Veins
    • 4.5.3 Human saphenous and umbilical veins biological material hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.5.4 Tissue Engineered Materials
    • 4.5.5 Tissue engineered biological material hemodialysis vascular grafts market, revenue estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5 Hemodialysis Vascular Graft Market: Regional Estimates & Trend Analysis, by Raw Materials

  • 5.1 Global Hemodialysis Vascular Market Share by Region, 2014 & 2025
  • 5.2 North America
    • 5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.2.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
    • 5.2.3 U.S.
      • 5.2.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.2.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
    • 5.2.4 Canada
      • 5.2.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.2.4.1 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
  • 5.3 Europe
    • 5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
    • 5.3.3 U.K.
      • 5.3.3.1 Market, market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.3.3.2 Market, market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
    • 5.3.4 Germany
      • 5.3.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.3.4.1 Market estimates and forecasts, 2014 - 2025, by raw material, (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.4.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
    • 5.4.3 Japan
      • 5.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.4.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
    • 5.4.4 China
      • 5.4.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.4.4.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.5.2 Market estimates and forecasts, by raw material,2014 - 2025 (USD Million)
    • 5.5.3 Brazil
      • 5.5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.5.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
    • 5.5.4 Mexico
      • 5.5.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.5.4.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
  • 5.6 MEA
    • 5.6.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
    • 5.6.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)
    • 5.6.3 South Africa
      • 5.6.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
      • 5.6.3.2 Market estimates and forecasts, by raw material, 2014 - 2025 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Company Profiles
    • 6.2.1 W. L. Gore & Associates.
      • 6.2.1.1 Company Overview
      • 6.2.1.2 Financial Performance
      • 6.2.1.3 Product Benchmarking
      • 6.2.1.4 Strategic Initiatives
    • 6.2.2 C. R. Bard, Inc.
      • 6.2.2.1 Company Overview
      • 6.2.2.2 Financial Performance
      • 6.2.2.3 Product Benchmarking
      • 6.2.2.4 Strategic Initiatives
    • 6.2.3 Terumo Medical Corporation.
      • 6.2.3.1 Company Overview
      • 6.2.3.2 Financial Performance
      • 6.2.3.3 Product Benchmarking
      • 6.2.3.4 Strategic Initiatives
    • 6.2.4 Lemaitre Vascular, Inc.
      • 6.2.4.1 Company Overview
      • 6.2.4.2 Financial Performance
      • 6.2.4.3 Product Benchmarking
      • 6.2.4.4 Strategic Initiatives
    • 6.2.5 Getinge AB.
      • 6.2.5.1 Company Overview
      • 6.2.5.2 Financial Performance
      • 6.2.5.3 Product Benchmarking
    • 6.2.6 VASCULAR GENESIS.
      • 6.2.6.1 Company Overview
      • 6.2.6.2 Financial Performance
      • 6.2.6.3 Product Benchmarking
    • 6.2.7 InnAVasc Medical, Inc.
      • 6.2.7.1 Company Overview
      • 6.2.7.2 Financial Performance
      • 6.2.7.3 Product Benchmarking
      • 6.2.7.4 Strategic Initiatives
    • 6.2.8 CryoLife, Inc.
      • 6.2.8.1 Company Overview
      • 6.2.8.2 Financial Performance
      • 6.2.8.3 Product Benchmarking
      • 6.2.8.4 Strategic Initiatives
    • 6.2.9 MERIT MEDICAL SYSTEMS, INC
      • 6.2.9.1 Company Overview
      • 6.2.9.2 Financial Performance
      • 6.2.9.3 Product Benchmarking
      • 6.2.9.4 Strategic Initiatives
    • 6.2.10 Proteon Therapeutics Inc.
      • 6.2.10.1 Company Overview
      • 6.2.10.2 Financial Performance
      • 6.2.10.3 Product Benchmarking
Back to Top